BSE filing, NSE: REMSONSIND. Summary written from the filing by ALFA Finder's alert engine.
Remsons Industries Ltd: key numbers
- Share price
- ₹90.97
- Market cap
- ₹317.3 Cr
- Revenue (annual)
- ₹468.7 Cr
- Net profit (annual)
- ₹18.05 Cr
- P/E (TTM)
- 18.4×Sector 31.4×
- Promoter holding
- 62.83%+0.00% QoQ
- FII holding
- 0.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Remsons Industries Ltd
All →Remsons Industries Management Change
Remsons Industries Limited has appointed Mrs. Shivani Kejriwal as an Additional Whole-time Director for five years. She is a promoter and will focus on sales and marketing strategy.
- Execution
- 5 years
Remsons Industries Management Change
Remsons Industries discloses the death of Whole Time Director Mr. Rahul Kejriwal on October 6, 2026. His cessation is reported under SEBI Regulation 30.
Remsons Industries Merger & Restructuring Worth ₹0.05 Cr
Remsons Industries approved the sale of its 26% stake in the Aircom Remsons Automotive JV for Rs. 0.05 Crore. The exit involves selling 52,000 shares to Aircom Group India.
- Value
- ₹0.05 Cr
Remsons Industries Annual General Meeting
Remsons Industries held its 54th Annual General Meeting on September 30, 2026. The meeting successfully passed all resolutions, including dividend declaration and employee stock options.
Remsons Industries Price Movement Clarification
Remsons Industries clarified to BSE Surveillance that the recent increase in share trading volume is purely market-driven. The company confirmed it has disclosed all price-sensitive information.
Remsons Industries Business Update
Remsons Industries confirms its Pardi manufacturing plant, halted by July flooding, has fully resumed operations. No disruption remains to the facility's normal functioning.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.